Oncology screenings took a worrying downturn during the pandemic. Recent data shows an upward trend in oncology screenings across cancer types, with non-small cell lung cancer showing the most positive upward trend. This is encouraging data, but may be spurred by the current virus surge and fears of future restrictions to office hours or access to in person care.
You may also be interested in:
News
COVID-19 Bi-Weekly Trend Insights
Although several common treatment options are currently used to care for patients diagnosed with COVID-19, the preferred treatment varies depending…
News
COVID-19 Bi-Weekly Trend Insights
As some restrictions for patient office visits are lifted, in-person visits look to be bouncing back. After a significant decline in…
News
COVID-19 Weekly Trend Insights
Symphony Health is tracking the impact of COVID-19 across all therapeutic areas and US regions, and will be publishing these findings in our Weekly…